Search research articles
Contact Us
Filters
Showing results (81-90 of 101) with videos related to
Page
of 11
Sort By:
Journal of Cellular Biochemistry
|
September 2, 2011
Decreased bone mineral density and reduced bone quality in H(+) /K(+) ATPase beta-subunit deficient mice
Reidar Fossmark, Astrid K Stunes, Christiane Petzold, et al.
Clinical and Translational Gastroenterology
|
March 20, 2026
Full title: Telomere length in celiac disease in a population-based cohort - a HUNT study
Reidar Fossmark, Henrik Hjorth-Hansen, Lisa Lirussi, et al.
Endocrine-Related Cancer
|
October 10, 2014
Hallmarks of gastrointestinal neuroendocrine tumours: implications for treatment
Annemiek Walenkamp, Guillermo Crespo, Felipe Fierro Maya, et al.
British Journal of Clinical Pharmacology
|
October 6, 2016
Netazepide, a gastrin/cholecystokinin-2 receptor antagonist, can eradicate gastric neuroendocrine tumours in patients with autoimmune chronic atrophic gastritis
Malcolm Boyce, Andrew R Moore, Liv Sagatun, et al.
International Journal of Molecular Sciences
|
February 7, 2020
Gastric Corpus Mucosal Hyperplasia and Neuroendocrine Cell Hyperplasia, but not Spasmolytic Polypeptide-Expressing Metaplasia, Is Prevented by a Gastrin Receptor Antagonist in H<sup>+</sup>/K<sup>+</sup>ATPase Beta Subunit Knockout Mice
Kristin Matre Aasarød, Helge Lyder Waldum, Astrid Kamilla Stunes, et al.
Circulation
|
March 23, 2005
Long-term serotonin administration induces heart valve disease in rats
Björn I Gustafsson, Karin Tømmerås, Ivar Nordrum, et al.
European Journal of Gastroenterology & Hepatology
|
August 6, 2008
Changes in gene expression of gastric mucosa during therapeutic acid inhibition
Kristin G Nørsett, Astrid Laegreid, Waclaw Kusnierczyk, et al.
BMC Endocrine Disorders
|
May 28, 2011
The peroxisome proliferator-activated receptor (PPAR) alpha agonist fenofibrate maintains bone mass, while the PPAR gamma agonist pioglitazone exaggerates bone loss, in ovariectomized rats
Astrid K Stunes, Irene Westbroek, Björn I Gustafsson, et al.
Scandinavian Journal of Gastroenterology
|
December 18, 2008
Interactions between gastric acid secretagogues and the localization of the gastrin receptor
Helge L Waldum, Per M Kleveland, Eiliv Brenna, et al.
Plastic and Reconstructive Surgery
|
December 9, 2025
Mechanical Manipulation of Fat: From Lipoaspirate to SVF Concentrate
Kjersti Ausen, Anne D B Rø, Gunnhild V Leirvik, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 101) with videos related to
Sort By:
Page
of 11
Journal of Cellular Biochemistry
|
September 2, 2011
Decreased bone mineral density and reduced bone quality in H(+) /K(+) ATPase beta-subunit deficient mice
Reidar Fossmark, Astrid K Stunes, Christiane Petzold, et al.
Clinical and Translational Gastroenterology
|
March 20, 2026
Full title: Telomere length in celiac disease in a population-based cohort - a HUNT study
Reidar Fossmark, Henrik Hjorth-Hansen, Lisa Lirussi, et al.
Endocrine-Related Cancer
|
October 10, 2014
Hallmarks of gastrointestinal neuroendocrine tumours: implications for treatment
Annemiek Walenkamp, Guillermo Crespo, Felipe Fierro Maya, et al.
British Journal of Clinical Pharmacology
|
October 6, 2016
Netazepide, a gastrin/cholecystokinin-2 receptor antagonist, can eradicate gastric neuroendocrine tumours in patients with autoimmune chronic atrophic gastritis
Malcolm Boyce, Andrew R Moore, Liv Sagatun, et al.
International Journal of Molecular Sciences
|
February 7, 2020
Gastric Corpus Mucosal Hyperplasia and Neuroendocrine Cell Hyperplasia, but not Spasmolytic Polypeptide-Expressing Metaplasia, Is Prevented by a Gastrin Receptor Antagonist in H<sup>+</sup>/K<sup>+</sup>ATPase Beta Subunit Knockout Mice
Kristin Matre Aasarød, Helge Lyder Waldum, Astrid Kamilla Stunes, et al.
Circulation
|
March 23, 2005
Long-term serotonin administration induces heart valve disease in rats
Björn I Gustafsson, Karin Tømmerås, Ivar Nordrum, et al.
European Journal of Gastroenterology & Hepatology
|
August 6, 2008
Changes in gene expression of gastric mucosa during therapeutic acid inhibition
Kristin G Nørsett, Astrid Laegreid, Waclaw Kusnierczyk, et al.
BMC Endocrine Disorders
|
May 28, 2011
The peroxisome proliferator-activated receptor (PPAR) alpha agonist fenofibrate maintains bone mass, while the PPAR gamma agonist pioglitazone exaggerates bone loss, in ovariectomized rats
Astrid K Stunes, Irene Westbroek, Björn I Gustafsson, et al.
Scandinavian Journal of Gastroenterology
|
December 18, 2008
Interactions between gastric acid secretagogues and the localization of the gastrin receptor
Helge L Waldum, Per M Kleveland, Eiliv Brenna, et al.
Plastic and Reconstructive Surgery
|
December 9, 2025
Mechanical Manipulation of Fat: From Lipoaspirate to SVF Concentrate
Kjersti Ausen, Anne D B Rø, Gunnhild V Leirvik, et al.
Page
of 11